Core Scientific announces third quarter 2026 results

5 Nov 2026

Released by Core Scientific, Inc.

MediaRelease.co Summary

Core Scientific, a Miami-based high-density colocation provider, reported third-quarter 2026 results. Colocation revenue rose nearly 60% sequentially to $215.4 million, and 485 MW of capacity was billing at September 30, representing over $700 million in annualized colocation revenue. Adjusted EBITDA was $133.6 million at a 57% margin, and construction under its second colocation agreement is under way across five campuses.

Original release

Core Scientific, Inc. (Nasdaq: CORZ), a leader in digital infrastructure for high-density colocation (“HDC”) services, today announced financial results for the third quarter ended September 30, 2026.

“Our execution at scale is translating into results, with a significant sequential increase in GAAP colocation revenue,” said Adam Sullivan, Chief Executive Officer of Core Scientific. “We are nearing full delivery under our first colocation agreement while construction under our second is underway across five campuses. With revenue growing and substantial contracted capacity still to deliver, we have built a strong foundation for our next phase of growth.”

Recent business developments

  • Colocation revenue increased nearly 60% sequentially to $215.4 million in the third quarter of 2026, driven by continued delivery of billing megawatts.
  • Billing for 485 MW of capacity as of September 30, 2026, representing over $700 million in average annualized colocation GAAP revenue.
  • Net income increased to $1.2 billion, benefiting from a non-cash gain in the change in fair value of warrants. Adjusted EBITDA more than tripled sequentially to $133.6 million, with margins expanding to 57%, up from 25%.

Financial summary and operating metrics (in millions, except billing megawatts)

  • Billing MW: 485 (Q3 2026), 395 (Q2 2026)
  • Colocation revenue: $215.4 (Q3 2026), $136.7 (Q2 2026), $15.0 (Q3 2025)
  • Total revenue: $232.9 (Q3 2026), $164.2 (Q2 2026), $81.1 (Q3 2025)
  • Gross profit: $123.3 (Q3 2026), $70.0 (Q2 2026), $3.9 (Q3 2025)
  • Adjusted EBITDA: $133.6 (Q3 2026), $41.1 (Q2 2026), $6.5 (Q3 2025)
  • Capital expenditures: $985.1 (Q3 2026), $797.5 (Q2 2026), $244.5 (Q3 2025)
  • Liquidity and DSRA: $1,744.2 (Q3 2026), $2,601.1 (Q2 2026), $694.8 (Q3 2025)

Net income (loss) for the quarters ended September 30, 2026 and June 30, 2026 were primarily driven by the change in fair value of warrants, reflecting changes in the Company’s stock price during the periods. Liquidity and DSRA comprises cash and cash equivalents, digital assets, revolver availability, and all restricted cash including the debt service reserve accounts.

Conference call and earnings presentation

Core Scientific hosted a conference call on Thursday, November 5, 2026, at 8:30 am Eastern Time, webcast live, with Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Senior Vice President, Investor Relations. A supplementary investor presentation and an audio replay are available on the Investor Relations section of the Core Scientific website, investors.corescientific.com.

Key details

Issued by
Core Scientific, Inc.
Published
5 Nov 2026
Publisher country
United States
Topics
Data Center

Source: https://investors.corescientific.com/news-events/press-releases/detail/146/core-scientific-announces-third-quarter-2026-results

MediaRelease.co ID: mr02942 · Markdown

← Back to Data Center overview